Regenevida
Recombinetics is a global biotechnology leader specializing in animal gene editing for biomedical research, animal agriculture, and human therapeutics. Their mission is to advance biomedical innovation through services, products, and expertise built on relationships and integrity, focusing on developing genetically engineered animals, including models for human diseases and improved livestock. They are committed to transparency, collaboration, and continuous improvement in their processes and products.
Industries
Nr. of Employees
small (1-50)
Products
Custom genetically engineered animals and germplasm
Delivered genetically modified animals and associated germplasm lines for research and commercialization across biomedical and agricultural applications.
Custom genetically engineered animals and germplasm
Delivered genetically modified animals and associated germplasm lines for research and commercialization across biomedical and agricultural applications.
Services
Custom gene‑edited swine model development
End‑to‑end creation of swine models carrying precise human disease or reporter mutations for preclinical evaluation.
Precision breeding and trait commercialization (food animals)
Precision introduction and deployment of production and health traits into commercial livestock lines using gene‑editing and laboratory breeding techniques.
Xenotransplantation and regenerative‑medicine platform development
Development services to generate host animals and protocols intended to support growth of human cells, tissues, or organs for regenerative medicine research.
Reproductive engineering and germline propagation services
Services for in vitro embryo production, cloning, and reproductive interventions to produce founder or recipient animals for propagation of edited genotypes.
Genomic screening, sequencing, and bioinformatics QC
Sequence analysis workflows using short‑ and long‑read technologies to validate edits, detect unintended integrations, and provide quality control reporting for genetic products.
Custom gene‑edited swine model development
End‑to‑end creation of swine models carrying precise human disease or reporter mutations for preclinical evaluation.
Precision breeding and trait commercialization (food animals)
Precision introduction and deployment of production and health traits into commercial livestock lines using gene‑editing and laboratory breeding techniques.
Xenotransplantation and regenerative‑medicine platform development
Development services to generate host animals and protocols intended to support growth of human cells, tissues, or organs for regenerative medicine research.
Reproductive engineering and germline propagation services
Services for in vitro embryo production, cloning, and reproductive interventions to produce founder or recipient animals for propagation of edited genotypes.
Genomic screening, sequencing, and bioinformatics QC
Sequence analysis workflows using short‑ and long‑read technologies to validate edits, detect unintended integrations, and provide quality control reporting for genetic products.
Expertise Areas
- Animal gene editing
- Large‑animal disease model development
- Xenotransplantation and regenerative medicine
- Precision breeding and livestock genetics
Key Technologies
- CRISPR/Cas genome editing
- TALEN gene editing
- Homology‑directed repair (HDR)
- In vitro embryo production and cloning